NL-OMON38001
Completed
N/A
Chemoradiation followed by surgery for patients with cT4 oesophageal cancer - TOR-study (T4 Oesophagus Resection)
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- oesophageal carcinoma
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Histologically proven squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic esophagus or gastro esophageal junction
- •Surgical irresectable (T4a and T4b), as determined by Endoscopic Ultra Sound (EUS), CT scan of neck, thorax and abdomen OR Positon Emission Tomography (PET)\-scan, without distant metastasis (T4a: ingrowth in pleura, pericardium, diaphragm, or adjacent peritoneum, T4b other adjacent structures,e.g. aorta, vertebral body, trachea)
Exclusion Criteria
- •cT4b oesophageal carcinoma with tracheobronchial involvement, as demonstrated on bronchoscopy after neoadjuvant treatment
- •Past or current history of malignancy other than entry diagnosis except for non\-melanomatous skin cancer, or curatively treated in situ carcinoma of the cervix, or malignancy more than 5 years prior to enrollment
- •Pregnancy (positive serum pregnancy test) and lactation
- •Clinically significant cardiovascular disease (including myocardial infarction, unstable angina, symptomatic congestive heart failure, serious uncontrolled cardiac arrhythmia) \<\= 1 year before enrollment
- •Active infection or other serious underlying medical condition which would impair the ability of the patient to receive the planned treatment
- •Dementia or altered mental status that would prohibit the understanding and giving of informed consent
- •Inadequate caloric\- and/or fluid intake
- •Weight loss \> 15%.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
T4 Oesophageal Resection.Esophageal carcinoma, Esophagectomy, Chemoradiotherapy, T4 tumorNL-OMON25753Academic Medical Center (AMC), Department of Surgery30
Completed
N/A
eoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinomas or squamous cell carcinomas of the esophagusISRCTN80832026Erasmus Medical Center, Department of Medical Oncology (Netherlands)350
Not Yet Recruiting
Phase 2
Chemoradiation followed by maintenance therapy for patients with locally advanced cutaneous angiosarcomaCutaneous angiosarcomaJPRN-UMIN000014397niversity of Tsukuba60
Completed
N/A
Induction chemoradiotherapy followed by surgery without mediastinal lymphnode disection in stage IIIA(bulkyN2)/IIIB non-small cell lung cancerJPRN-UMIN000006022Iseikai Hospital45
Completed
Phase 1
Preoperative chemoradiation therapy combined with peptide vaccination for T3-pancreatic cancer: prospective phase I/II studyT3(UICC)-pancreatic cancerJPRN-UMIN000004422Department of Gastroenterological Surgery, Osaka Medical Center for cancer & Cardiovascular Diseases50